Literature DB >> 26776193

PERSONALIZED HYPOTHESIS TESTS FOR DETECTING MEDICATION RESPONSE IN PARKINSON DISEASE PATIENTS USING iPHONE SENSOR DATA.

Elias Chaibub Neto1, Brian M Bot, Thanneer Perumal, Larsson Omberg, Justin Guinney, Mike Kellen, Arno Klein, Stephen H Friend, Andrew D Trister.   

Abstract

We propose hypothesis tests for detecting dopaminergic medication response in Parkinson disease patients, using longitudinal sensor data collected by smartphones. The processed data is composed of multiple features extracted from active tapping tasks performed by the participant on a daily basis, before and after medication, over several months. Each extracted feature corresponds to a time series of measurements annotated according to whether the measurement was taken before or after the patient has taken his/her medication. Even though the data is longitudinal in nature, we show that simple hypothesis tests for detecting medication response, which ignore the serial correlation structure of the data, are still statistically valid, showing type I error rates at the nominal level. We propose two distinct personalized testing approaches. In the first, we combine multiple feature-specific tests into a single union-intersection test. In the second, we construct personalized classifiers of the before/after medication labels using all the extracted features of a given participant, and test the null hypothesis that the area under the receiver operating characteristic curve of the classifier is equal to 1/2. We compare the statistical power of the personalized classifier tests and personalized union-intersection tests in a simulation study, and illustrate the performance of the proposed tests using data from mPower Parkinsons disease study, recently launched as part of Apples ResearchKit mobile platform. Our results suggest that the personalized tests, which ignore the longitudinal aspect of the data, can perform well in real data analyses, suggesting they might be used as a sound baseline approach, to which more sophisticated methods can be compared to.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26776193

Source DB:  PubMed          Journal:  Pac Symp Biocomput        ISSN: 2335-6928


  10 in total

1.  Leveraging mobile health applications for biomedical research and citizen science: a scoping review.

Authors:  Hannah Schmitz; Carol L Howe; David G Armstrong; Vignesh Subbian
Journal:  J Am Med Inform Assoc       Date:  2018-12-01       Impact factor: 4.497

Review 2.  [Remote assessment of idiopathic Parkinson's disease : Developments in diagnostics, monitoring and treatment].

Authors:  U Kleinholdermann; J Melsbach; D J Pedrosa
Journal:  Nervenarzt       Date:  2019-12       Impact factor: 1.214

Review 3.  Evaluation, Acceptance, and Qualification of Digital Measures: From Proof of Concept to Endpoint.

Authors:  Jennifer C Goldsack; Ariel V Dowling; David Samuelson; Bray Patrick-Lake; Ieuan Clay
Journal:  Digit Biomark       Date:  2021-03-23

4.  Remote health diagnosis and monitoring in the time of COVID-19.

Authors:  Joachim A Behar; Chengyu Liu; Kevin Kotzen; Kenta Tsutsui; Valentina D A Corino; Janmajay Singh; Marco A F Pimentel; Philip Warrick; Sebastian Zaunseder; Fernando Andreotti; David Sebag; Georgy Kopanitsa; Patrick E McSharry; Walter Karlen; Chandan Karmakar; Gari D Clifford
Journal:  Physiol Meas       Date:  2020-11-10       Impact factor: 2.688

5.  Precision Medicine in Parkinson's Disease - Exploring Patient-Initiated Self-Tracking.

Authors:  Sara Riggare; Maria Hägglund
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

6.  Digital biomarkers for Alzheimer's disease: the mobile/ wearable devices opportunity.

Authors:  Lampros C Kourtis; Oliver B Regele; Justin M Wright; Graham B Jones
Journal:  NPJ Digit Med       Date:  2019-02-21

7.  Crowdsourcing digital health measures to predict Parkinson's disease severity: the Parkinson's Disease Digital Biomarker DREAM Challenge.

Authors:  Solveig K Sieberts; Jennifer Schaff; Marlena Duda; Bálint Ármin Pataki; Ming Sun; Phil Snyder; Jean-Francois Daneault; Federico Parisi; Gianluca Costante; Udi Rubin; Peter Banda; Yooree Chae; Elias Chaibub Neto; E Ray Dorsey; Zafer Aydın; Aipeng Chen; Laura L Elo; Carlos Espino; Enrico Glaab; Ethan Goan; Fatemeh Noushin Golabchi; Yasin Görmez; Maria K Jaakkola; Jitendra Jonnagaddala; Riku Klén; Dongmei Li; Christian McDaniel; Dimitri Perrin; Thanneer M Perumal; Nastaran Mohammadian Rad; Erin Rainaldi; Stefano Sapienza; Patrick Schwab; Nikolai Shokhirev; Mikko S Venäläinen; Gloria Vergara-Diaz; Yuqian Zhang; Yuanjia Wang; Yuanfang Guan; Daniela Brunner; Paolo Bonato; Lara M Mangravite; Larsson Omberg
Journal:  NPJ Digit Med       Date:  2021-03-19

8.  Disentangling personalized treatment effects from "time-of-the-day" confounding in mobile health studies.

Authors:  Elias Chaibub Neto; Thanneer M Perumal; Abhishek Pratap; Aryton Tediarjo; Brian M Bot; Lara Mangravite; Larsson Omberg
Journal:  PLoS One       Date:  2022-08-04       Impact factor: 3.752

9.  The mPower study, Parkinson disease mobile data collected using ResearchKit.

Authors:  Brian M Bot; Christine Suver; Elias Chaibub Neto; Michael Kellen; Arno Klein; Christopher Bare; Megan Doerr; Abhishek Pratap; John Wilbanks; E Ray Dorsey; Stephen H Friend; Andrew D Trister
Journal:  Sci Data       Date:  2016-03-03       Impact factor: 6.444

10.  Smartphones as new tools in the management and understanding of Parkinson's disease.

Authors:  Andrew D Trister; E Ray Dorsey; Stephen H Friend
Journal:  NPJ Parkinsons Dis       Date:  2016-03-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.